Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
19.64
+0.11 (0.56%)
At close: Dec 5, 2025, 4:00 PM EST
19.80
+0.16 (0.81%)
After-hours: Dec 5, 2025, 7:59 PM EST
TNXP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 10.3 | 10.09 | 7.77 | - | - | - | |
| Revenue Growth (YoY) | -8.79% | 29.94% | - | - | - | - | |
| Cost of Revenue | 6.77 | 7.77 | 4.74 | - | - | - | |
| Gross Profit | 3.53 | 2.33 | 3.03 | - | - | - | |
| Selling, General & Admin | 67.59 | 40.1 | 34.75 | 30.22 | 23.47 | 14.35 | |
| Research & Development | 35.84 | 39.97 | 86.66 | 81.88 | 68.84 | 36.16 | |
| Operating Expenses | 103.43 | 80.07 | 121.41 | 112.09 | 92.31 | 50.51 | |
| Operating Income | -99.9 | -77.74 | -118.38 | -112.09 | -92.31 | -50.51 | |
| Interest & Investment Income | 3.65 | - | - | - | 0.03 | 0.05 | |
| Other Non Operating Income (Expenses) | -0.88 | 6.67 | 1.72 | 1.87 | - | - | |
| EBT Excluding Unusual Items | -97.13 | -71.08 | -116.66 | -110.22 | -92.29 | -50.46 | |
| Impairment of Goodwill | -0.04 | -1 | - | - | - | - | |
| Asset Writedown | 0.04 | -57.96 | - | - | - | - | |
| Pretax Income | -99.22 | -130.04 | -116.66 | -110.22 | -92.29 | -50.46 | |
| Net Income | -99.22 | -130.04 | -116.66 | -110.22 | -92.29 | -50.46 | |
| Preferred Dividends & Other Adjustments | - | - | - | 6.66 | - | 1.71 | |
| Net Income to Common | -99.22 | -130.04 | -116.66 | -116.88 | -92.29 | -52.17 | |
| Shares Outstanding (Basic) | 6 | 1 | - | - | - | - | |
| Shares Outstanding (Diluted) | 6 | 1 | - | - | - | - | |
| EPS (Basic) | -16.22 | -176.60 | - | - | - | - | |
| EPS (Diluted) | -16.22 | -176.60 | - | - | - | - | |
| Free Cash Flow | -76.32 | -61.05 | -109.9 | -146.2 | -110.86 | -57.13 | |
| Free Cash Flow Per Share | -12.48 | -82.90 | - | - | - | - | |
| Gross Margin | 34.31% | 23.07% | 38.97% | - | - | - | |
| Operating Margin | -969.97% | -770.20% | -1523.94% | - | - | - | |
| Profit Margin | -963.39% | -1288.25% | -1501.78% | - | - | - | |
| Free Cash Flow Margin | -741.06% | -604.76% | -1414.75% | - | - | - | |
| EBITDA | -97.46 | -74.32 | -114.09 | -110.84 | -92.26 | -50.48 | |
| D&A For EBITDA | 2.43 | 3.42 | 4.29 | 1.25 | 0.05 | 0.03 | |
| EBIT | -99.9 | -77.74 | -118.38 | -112.09 | -92.31 | -50.51 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.